Glaxo Loses Patent For Seretide/Advair In U.K.
GlaxoSmithKline has lost a U.K. patent challenge from generic drug makers Cipla and Ivax on its top-selling athma drug Seretide (Advair)....To view the full article, register now.
Already a subscriber? Click here to view full article